These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5386195)

  • 21. Polymorphic acetylation of sulphamethazine in a Zimbabwe population.
    Nhachi CF
    J Med Genet; 1988 Jan; 25(1):29-31. PubMed ID: 3351888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylation of procainamide and isoniazid by a rat liver-N-acetyl-transferase.
    Kattner E; Dubbels R; Schloot W
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):81-4. PubMed ID: 6974093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of the phenotype of INH inactivation in pulmonary tuberculosis by means of an indirect method on the model of sulfamethazine].
    Powłowska I; Rakowska Z
    Pneumonol Pol; 1978 Aug; 46(8):605-12. PubMed ID: 714703
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
    Hein DW; Weber WW
    Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.
    Ahmad RA; Rogers HJ; Vandenburg M; Wright P
    Br J Clin Pharmacol; 1981 Jul; 12(1):83-6. PubMed ID: 7248142
    [No Abstract]   [Full Text] [Related]  

  • 26. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The polymorphic acetylation of dapsone in man.
    Gelber R; Peters JH; Gordon GR; Glazko AJ; Levy L
    Clin Pharmacol Ther; 1971; 12(2):225-38. PubMed ID: 5554939
    [No Abstract]   [Full Text] [Related]  

  • 28. Polymorphic acetylation of sulphamethazine in rural bedouin and urban-dwellers in Saudi Arabia.
    Islam SI
    Xenobiotica; 1982 May; 12(5):323-8. PubMed ID: 7136000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
    Nair CR; Gupta RC; Varshneya AK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphic acetylation of nitrazepam.
    Karim AK; Evans DA
    J Med Genet; 1976 Feb; 13(1):17-9. PubMed ID: 775091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
    Grant DM; Mörike K; Eichelbaum M; Meyer UA
    J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
    Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
    Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a novel N-methyl-D-aspartate receptor antagonist (SM-18400): identification of an N-acetylated metabolite and pre-clinical assessment of N-acetylation polymorphism.
    Yabuki M; Kon-Ya Y; Kataoka M; Shimizudani T; Akao K; Ito M; Kanamaru H; Nakatsuka I
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):21-9. PubMed ID: 14503661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    Martell KJ; Levy GN; Weber WW
    Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of an MAO inhibitor, phenelzine, on acetylation of isoniazid by isolated perfused rat liver].
    Notter D; Catau G; Besson S
    C R Seances Soc Biol Fil; 1978; 172(3):529-30. PubMed ID: 153184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of the acetylator phenotype in Andalusia].
    Saucedo Sánchez R; Mayor Morente B; Puche Cañas E
    Rev Clin Esp; 1985 Jun; 177(2):75-7. PubMed ID: 4048566
    [No Abstract]   [Full Text] [Related]  

  • 39. Arylamine N-acetyltransferase activity of the human placenta.
    Derewlany LO; Knie B; Koren G
    J Pharmacol Exp Ther; 1994 May; 269(2):756-60. PubMed ID: 8182542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylator status of kwashiorkor children in Ibadan (south-west Nigeria).
    Jeyakumar LH; Arowoshegbe UA; Akinyinka OO; Akinbami FO; Bababunmi EA
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):57-62. PubMed ID: 2384118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.